Trial Profile
Linezolid vs. vancomycin/oxacillin/dicloxacillin in the treatment of catheter-related Gram-positive bloodstream infections
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Linezolid (Primary) ; Linezolid (Primary) ; Dicloxacillin; Oxacillin; Vancomycin
- Indications Bacteraemia; Catheter infections; Gram-positive infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 21 Jun 2019 Trial has been completed in Ireland, according to European Clinical Trials Database record.
- 15 Sep 2009 Actual number of patients changed from 726 to 739 as reported by ClinicalTrials.gov.
- 20 Sep 2007 Results reported at ICAAC 2007.